[Interest and limit of a free light chain immunoassay in serum and urine for the diagnosis and the follow-up of monoclonal dysglobulinemia].
This work aims to define the interest and the limits of free light chain (FLC) determination in serum and urine for the investigation of monoclonal gammopathies. Based on the study of nine typical cases extracted from laboratory practice, the authors demonstrate the interest of this determination for the diagnosis and the monitoring of FLC and non secretory myelomas. This test is also useful for the evaluation of response to chemotherapy and the early detection of relapses in intact immunoglobulin multiple myelomas. These results are discussed in the light of the literature with a special emphasis on AL amyloidosis and monoclonal gammapathy of undetermined significance (MGUS). Finally the authors underline some limitations leading to an overestimation of the results in certain patients together with the difficulty to interpret data when a renal damage is associated.
Lopez
J
J
Laboratoire d'immunologie, Centre hospitalier Lyon Sud, Pierre-Bénite.
Dauwalder
O
O
Joly
P
P
Dimet
I
I
Bienvenu
J
J
Bernon
H
H
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000097:blood* / Q000652:urine*; D008297:Male; D008875:Middle Aged; D010265:Paraproteinemias / Q000097:blood / Q000175:diagnosis* / Q000652:urine
D007147:Immunoglobulin Light Chains